To address a continuing nationwide shortage, more than 77,000 doses of RSV shots for infants were released Thursday by the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration.
Nov 16, 2023
0
0
A RSV new therapy for infants, called nirsevimab, started shipping in September. By mid-October, demand for nirsevimab, sold under the brand name Beyfortus, had already outstripped supply, according to the pharmaceutical ...
Nov 13, 2023
0
0
The world is entering a new era of vaccines. Following the success of COVID-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus's structure, putting a host of new vaccines on the horizon.
Oct 30, 2023
0
0
Researchers from Karolinska Institutet, among others, have developed a prognostic model that identifies the children most at risk of severe RSV infection. The study, published in The Lancet Digital Health, can show which ...
Oct 26, 2023
0
26
Demand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for high-risk infants.
Oct 24, 2023
0
0
Influenza, COVID-19, the common cold and respiratory syncytial virus (RSV) are among the respiratory viruses that will be circulating this fall and winter seasons. These highly contagious viruses cause similar symptoms, making ...
Oct 20, 2023
0
0
Maternal vaccination with a bivalent stabilized prefusion F subunit respiratory syncytial virus (RSV) vaccine (RSVpreF) is projected to reduce the clinical and economic burden of RSV lower respiratory tract illness (LRTI) ...
Oct 16, 2023
0
7
As cold and flu season ramps up, health care experts are once again on high alert for the possibility of a tripledemic, or a surge brought on by the respiratory viruses that cause COVID-19, the flu and respiratory syncytial ...
Oct 12, 2023
0
10
Toilet bowls reveal much about the health of a community, alerting scientists to coming outbreaks of flu and other seasonal viruses, researchers say.
Oct 11, 2023
0
1
Most respiratory syncytial virus (RSV)-associated hospitalizations among seniors aged ≥60 years occur in those aged ≥75 years, and although RSV is less common among seniors, it is associated with more severe disease than ...
Oct 9, 2023
0
1
